- European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancerPublication without faculty affiliation
- Niraparib2021 | First Faculty of Medicine
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | Second Faculty of Medicine, First Faculty of Medicine
- BRCA1 and BRCA2 - pathologist's starting kit2016 | Second Faculty of Medicine
- Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis2022 | First Faculty of Medicine
- A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)2022 | Third Faculty of Medicine